-As Experts Endorse it for its Bioavailability, Patient Compliance
Poised to reduce the prevalence of malaria in the country, Elbe Pharma Nigeria Limited on Wednesday unveiled Amatem Forte Softgel- an innovative product, with lots of benefits for the patients, than what is derived from the normal Artemether Lumefantrine tablets.
The official unveiling of the product, which was well attended by medical experts, held at the MRC Hall, of the Lagos State University Teaching Hospital (LASUTH).In attendance were: The Managing Director, Elbe Pharma Nigeria Ltd., Sir Uchenna Obiakor; Pharmanews Publisher, Sir Ifeanyi Atueyi; General Manager, Elbe Pharma, Shiva Kumar; Prof. O.O Adedeji; Dr Omoniyi Kayode Yemitan–Department of Pharmacology, Therapeutic and Toxicology LASUTH; Dr W.B Mutiu, and others.
Speaking on the findings of a comparative study conducted on the bioavailability, efficacy and toxicity of Amatem Forte Softgel and another known brand of Artemeter –Lumefantrine tablet formulation, by a group of researchers from LASUTH, Dr Omoniyi Yemitan noted that Amatem Softgel was found to be more present in the blood stream than other brands of malaria tablets.
According to him: “It is expected that most of the drugs we take get to the blood stream that is what we call bioavailability. What we found out from the bioavailability study is that Amatem Softgel is more present in the bloodstream than the tablets. The implication is that Amatem Softgel can quickly attack malaria parasite in the bloodstream, than tablets”.
He however stated that the toxicity study of Amatem Softgel did not reveal any side effects of the drug on patients, and thus urged the pharmaceutical company to do an extension of the toxicity study in the future. “The study was focused on how much of the product is found in the blood stream and its effectiveness in treating malaria, and these showed significant positive results”.
The Managing Director, Elbe Pharma, Nigeria Ltd., Sir Uchenna Obiakor also attested to the efficacy of the drug, with the level of demand for the product the company gets daily. He said: “People have started testifying about the efficacy of the product, in fact, the quantity of the product that is moving right now is unbelievable. And it may interest you to know that some persons are already addicted to the Amatem Softgel”.
On the affordability of the product to the Nigerian populace, he said they have tried so much to ensure that everyone can afford the product, not minding the high technology used in producing it. “Yes we have done tremendous work on this to ensure that the masses can easily afford the product. The technology is quite different from that of the tablet, and going by this technology, it may be difficult for a lot of people to afford it, but we tried as much as we can to reduce the price, to ensure that every Tom, Dick and Harry can afford it. It is easily affordable, compared to the therapeutic benefits derived from the formulation.
In his contribution, the Brand Manager, Elbe Pharma, Mr Augustine Aisabokhale, described Amatem Softgel as an innovative product, which has a lot of benefits for patients, that is, benefits that are not derivable from normal Artemether- Lumefantrine tablets. “There is increased bioavailability, also there is patient’ complaint, because it is quoted from taste, it is not bitter, and easy to swallow.
“Amatem Softgel does not have any report regarding side effects. It is also affordable, though it is more capital intensive to produce, regarding the technology behind the production. However, we have tried as much as possible to reduce the price to the bareast minimum for the affordability of the masses”.